C08F 120/68
Esters
C08F120/68 (Esters) appears on 18 US grants and 27 published applications in this corpus.
Search patents in C08F- Granted patents
- 18
- Published applications
- 27
- Assignees
- 26
- Inventors
- 74
- Latest grant
- 29 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 2 |
| 2017 | 1 | 5 |
| 2018 | 4 | 3 |
| 2019 | 4 | 1 |
| 2020 | 1 | 2 |
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 2 | 1 |
| 2024 | 3 | 3 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- High-temperature stereolithography apparatus and methods of use thereof29 Apr 2025US 12,285,910 B2Virginia Tech Intellectual Properties, Inc.
- Siloxane and a method for preparing the same31 Dec 2024US 12,180,310 B2Shin-Etsu Chemical Co., Ltd.
- Compositions and methods for liquid phase oligonucleotide synthesis5 Nov 2024US 12,134,630 B2Hongene Biotech Corporation
- Compositions and methods for liquid phase oligonucleotide synthesis20 Aug 2024US 12,065,460 B2Hongene Biotech Corporation
- Compositions and methods for liquid phase oligonucleotide synthesis26 Dec 2023US 11,851,454 B2Hongene Biotech Corporation
- Fluorinated fluorine-containing compound, and fluorine-containing fluoropolymer and surface treatment agent using same30 Jul 2026US 2026/0217641 A1AGC Inc.
- Curable composition and cured product17 Apr 2025US 2025/0122316 A1Dexerials Corporation
- Compositions and methods for liquid phase oligonucleotide synthesis30 Jan 2025US 2025/0034192 A1Hongene Biotech Corporation
- Compound, curable resin composition, cured product, diffractive optical element, and augmented reality glasses7 Nov 2024US 2024/0368076 A1FUJIFILM Corporation
- Compositions and methods for liquid phase oligonucleotide synthesis21 Mar 2024US 2024/0092817 A1Hongene Biotech Corporation
Most cited
By later US patents
- Alkoxylated unsaturated fatty acids and uses thereof2US 10,100,137 B2Elevance Renewable Sciences, Inc. · 2018
- Compositions and methods for liquid phase oligonucleotide synthesis2US 11,851,454 B2Hongene Biotech Corporation · 2023
- Polymerizable compound, polymerizable composition, optical material, optical element and optical head device2US 8,335,148 B2Asahi Glass Company, Limited · 2012
- Liquid developer and method of producing same1US 10,175,597 B2Canon Kabushiki Kaisha · 2019